Levaquin
Product Images NDC 21695-464
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Levaquin (NDC 21695-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (A23a1cca Bc3e 48c5 Abd9 82eddb52e91b 02)
Figure 3 (A23a1cca Bc3e 48c5 Abd9 82eddb52e91b 03)
The text appears to be a prescription medication label for a tablet named "O~ 500 mg." The instructions suggest taking it orally (p.o.). The second line reads "A —+— S00mgix," which is not clear what it means as it could be an error in . The third line mentions "Plasma Concentration (ug/mL)," which might imply the medication's effect on the blood plasma levels. Overall, this text does not provide much useful information.*
Levaquin 500mg (A23a1cca Bc3e 48c5 Abd9 82eddb52e91b 04)
Levaquin 750mg (A23a1cca Bc3e 48c5 Abd9 82eddb52e91b 05)
Levaquin 750mg is a prescription drug indicated for the treatment of bacterial infections. The drug comes in tablet form and is identified by the National Drug Code (NDC) 21896-519-07 and the product ID PLO51907. Each tablet contains 750mg of the active ingredient Levooxacn. This medication is only available through a prescription from a healthcare provider and should be stored out of the reach of children. The drug is manufactured by Janssen Ortho LLC in Gurabo, Puerto Rico.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.